Introduction
The combination of plasma cell dyscrasia, polyneuropathy and endocrinopathy was first reported by Shimpo in 1968, and since then, over thirty cases have been reported from Japan (Takatsuki et al., 1977) . Recently, non-Japanese patients with this syndrome have been described in the American (Trentham, Masi and Marker, 1976;  Meshinpour, Myung and Kramer, 1977; Bardwick et al., 1980) and the European literature (Amiel, Machover and Droz, 1975; Lievre, 1977; Moya-Mir et al., 1980) Permission for a post-mortem was refused.
Discussion
The plasma cell dyscrasia syndrome has become a well-recognized entity in Japan, being observed in 32 patients (Takatsuki et al., 1977 (Amiel et al., 1975; Lievre, 1977; Moya-Mir, 1980 ). This present case is the sixth in a caucasian, and as in previous reports the patient exhibited the classic triad of plasma cell dyscrasia, polyneuropathy and endocrinopathy; additionally, the patient was found to have paraprotein deposition, a feature not previously described.
A plasma cell dyscrasia was clearly present, with an increase in the marrow plasma cell population, and the presence of an IgA lambda M band in the serum, and lambda light chains in the urine. While these lambda chains are important as diagnostic markers, they may also be of pathogenetic significance, as in multiple myeloma, where they may be deposited in the skin, or form amyloid fibrils (Cohen and Cathcart, 1974; Linke et al., 1973) . Furthermore, the antibody activity recently demonstrated in some paraproteins (Seligman and Brouet, 1973; Osterland and Espinoza, 1975) 
